1. Home
  2. ENGN

ENGN

enGene Holdings Inc.

as 04-22-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Founded: 1999 Country:
Canada
Canada
Employees: N/A City: SAINT-LAURENT
Market Cap: 654.9M IPO Year: N/A
Target Price: $34.40 AVG Volume (30 days): 51.0K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $6.69 - $47.17 Next Earning Date: 03-11-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: